pharma · Waldenstrom Macroglobulinemia · Non Small Cell Lung Cancer · CLRB
Cellectar Biosciences
Cellectar Biosciences trial registry — 18 ClinicalTrials.gov studies with program phase, status, and indication context.
100 Campus Dr, 207, Florham Park, New Jersey 07932, US HQ
21 Employees
Public company Type
CLRB · NYSE Ticker
Company details
- Status
- Public
- HQ
- 100 Campus Dr, 207, Florham Park, New Jersey 07932, US
- Employees
- 21
- Programs
- 17
- Drugs
- 7
- Patents
- 7
Cellectar Biosciences clinical trials
Registry index of 18 ClinicalTrials.gov studies linked to Cellectar Biosciences programs — each row shows trial ID, program name, phase, status, and indication.
Cellectar Biosciences trial registry — 18 ClinicalTrials.gov studies with program phase, status, and indication context.
Recent trial activity
Latest clinical program signals indexed for Cellectar Biosciences.
-
POTASSIUM IODIDE — Phase 2
Clinical update -
Iopofosine I 131 single dose — Phase 2
Clinical update -
I-131-CLR1404 Injection — Phase 2
Clinical update -
RNL-Vascostem® — Unknown
Clinical update -
Paclitaxel — Phase 3
Clinical update -
I-124-CLR1404 — Phase 2
Clinical update -
NOV-002 — Phase 2
Clinical update -
NOV-002 — Phase 2
Clinical update